Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Torrette
Clinical trial register · Italy

Clinical Trials in Torrette, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Torrette

15 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Bayer
Phase 2
360
Acquaviva delle Fonti, Milan, Roma, Torrette
2026-09-01
Recruiting
Takeda
Phase 3
183
Catania, Pavia, Pescara, Roma, Torrette
2026-01-14
Recruiting
ALX Oncology Inc.
Phase 2
120
Torrette, Genova, Bergamo, Bologna, Milan, Monza, Novara
2025-12-10
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Recruiting
BioNTech SE
Phase 3
558
Aviano, Lucca, Milan, Monza, Pisa, Roma, Torrette
2025-10-30
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Milan, Ranica, Torrette
2025-09-19
Recruiting
Takeda
Phase 3
1,088
Torrette, Rome, Milan, Rozzano, Padova, Florence, Pisa
2025-03-03
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Caserta, Cremona, Naples, Rozzano, San Giovanni Rotondo, Torrette, Udine
2024-11-22
Recruiting
X4 Pharmaceuticals
Phase 3
176
Torrette, Brescia, Genova, Meldola, Monza, Roma, Torino
2024-06-06
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
Avalyn Pharma Inc.
Phase 2
375
Torrette, Naples, Bologna, Venezia, Pavia, Milan, Rozzano, Catania
2024-04-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Torrette, Castellana Grotte, Bologna, Catania, Foggia, Florence, Modena, Milan
2022-12-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Naples, Genoa, Monza (MB), Catania (CT), Torrette, Trento, Livorno, Prato
2022-03-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Torrette, Rome, Rozzano, Florence, Lecce, Milan, Modena, Udine
2020-07-06
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Torrette, Bologna, Rome, Faenza, Lugo, Cattolica, Milan, Ravenna
2019-10-02
Active, closed
AbbVie
Phase 3
1,336
Torrette, Genoa, Rozzano, Milan, Rho, Rome, Florence, Negrar
2018-04-09
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-italy/city/torrette

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Torrette.

How many clinical trials are recruiting in Torrette?

10 of the 15 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Torrette), 15 studies
PhaseStudiesRecruitingShare
Phase 39560%
Phase 25433.3%
Observational116.7%

Most active sponsors

Lead sponsors with the most studies (Torrette)
Lead sponsorStudiesRecruiting
Seagen, a wholly owned subsidiary of Pfizer20
Takeda22
AbbVie10
Alexion Pharmaceuticals, Inc.11
ALX Oncology Inc.11
AstraZeneca11
Avalyn Pharma Inc.10
Bayer11
BioNTech SE11
IRCCS Azienda Ospedaliero-Universitaria di Bologna11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.